Clinical Trial Update: Stopping Aminosalicylate Therapy in Inactive Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the safety and feasibility of stopping aminosalicylate therapy in patients with inactive Crohn's disease; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Aminosalicylate therapy (mesalamine) (mesalamine)

Snippet

Sponsor: Alimentiv Inc. | Conditions: Crohn Disease, Remission | Phase 4 | Status: ACTIVE_NOT_RECRUITING